Ephedra.
Its stems carry ephedrine-type alkaloids acting on adrenergic receptors, so heart rate rises, airways relax and resting metabolic rate lifts. A whole-body stimulant, not a targeted one.
- Category
- Herb
What Ephedra is, and what it does.
- Does it work
- It suits people working with traditional herbal preparations under professional guidance. Ephedrine-alkaloid supplements have been off the US market since 2004, so regulation sets availability.
- How much to take
- No dose figure is on record, and alkaloid content swings with species and batch, so a gram of herb is not a fixed amount of active. Any use belongs under professional supervision.
- Time to feel it
- Stimulant effects arrive quickly, usually inside 30 to 60 minutes of an oral dose, and they are felt rather than measured.
- The first dose
- Day one is noticeable: heart rate up, alertness up, often a warm feeling and some jitteriness. That is the pharmacology doing exactly what it does.
- With regular use
- The metabolic rate effect attenuates with repeated exposure as adrenergic receptors downregulate, so the third week does not feel like the first.
- How well tolerated
- Stimulant effects on heart rate and blood pressure cannot be separated from any other effect by dosing. Check with a clinician first, especially if you take stimulant or blood pressure medicine.
- How it feels
- Alert, warm, sometimes wired. Heart rate is noticeable, hands can feel unsteady, appetite usually drops. Nothing subtle about it.
- The overlooked benefit
- Its alkaloids are the chemical ancestors of modern decongestant medicines, which is also why the isolated compound is a controlled precursor rather than a shelf ingredient.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- resting metabolic rate and thermogenesisMeta-analysis
- appetite regulationRandomised trial
- body composition during energy restrictionMeta-analysis
- bronchial smooth muscle relaxationNarrative review
- cardiovascular and central stimulant effectsNarrative review
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Ephedrine alkaloids act as indirect sympathomimetics, releasing noradrenaline and stimulating adrenergic receptors. Caffeine antagonises adenosine receptors and inhibits phosphodiesterase, so the cyclic AMP signal that adrenergic stimulation starts is sustained rather than cleared. The two together raise heart rate and blood pressure more than either alone, which is why the combination was historically both popular and the source of reported cardiovascular events. Read this pairing as a caution, not an endorsement.
Green tea catechins inhibit catechol-O-methyltransferase, the enzyme that inactivates noradrenaline. Ephedra alkaloids work by pushing noradrenaline out of nerve terminals. Slowing the clearance of a transmitter while increasing its release stacks two effects on the same adrenergic signal. The practical consequence is a stronger and longer stimulant response, including on heart rate.
Beta-2 adrenergic stimulation activates the sodium-potassium ATPase and shifts potassium from plasma into cells. Ephedrine alkaloids are beta-2 agonists among their other actions, so sustained high intake can lower measured serum potassium. This is a redistribution, not a loss of total body potassium. It matters most for anyone already low or on a potassium-wasting diuretic.
L-theanine raises alpha-wave activity and blunts some of the subjective jitteriness of stimulants. It does not act on adrenergic receptors and does not lower heart rate or blood pressure in any reliable way. Any smoothing of the ephedra experience would be perceptual rather than cardiovascular. Do not read it as a safety measure.
Ephedrine is a weak base excreted largely unchanged by the kidney, and its clearance is strongly pH dependent. Acidifying the urine, as large ascorbic acid doses can, increases the ionised fraction in the tubule and speeds elimination. The same is true in the other direction: alkalinising agents slow clearance and prolong exposure. This is a textbook pharmacokinetic interaction rather than a nutritional one.
Bicarbonate raises urinary pH, which increases the un-ionised fraction of ephedrine available for tubular reabsorption. Less drug leaves in the urine and plasma levels stay higher for longer. Athletes who take bicarbonate for buffering may not realise they are extending a stimulant's half-life. The direction of this effect is well characterised.
Magnesium stabilises cardiac membrane potential and is used clinically in catecholamine-driven rhythm disturbance. Adequate magnesium status is relevant background when adrenergic tone is raised. This is a plausibility argument from physiology, not evidence that magnesium offsets ephedra's cardiovascular load. It should not be presented as a countermeasure.
Nothing specific on file for Ephedra. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Ephedra actually does.
Ephedra's effects come from alkaloids like ephedrine and pseudoephedrine that work indirectly, releasing stored noradrenaline and also binding adrenaline receptors directly.
One receptor pathway narrows blood vessels in the skin and nose, which is why the isolated alkaloid was used as a decongestant.
Other receptors speed up the heart and relax airway muscle at the same time as any metabolic effect, so you can't dose around one without the other.
Ephedrine can raise resting calorie burn by triggering fat breakdown and heat production, but that effect fades as the body adapts with repeated use.
Where Ephedra comes from.
It is a scrubby desert plant whose green stems contain natural stimulant compounds closely related to what is in decongestants. How much of that compound you get depends on the exact species and batch, which is a large part of why it became a problem in supplements. Ephedrine-alkaloid supplements have been off the US market since 2004.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A jointed, near-leafless shrub of arid Central and East Asia. The green stems carry the alkaloids. The woody root does not and is used separately in traditional practice.
Cut stems are extracted with water or dilute alcohol. The alkaloids are weak bases, so pH is adjusted to pull them into or out of the aqueous phase.
Basifying the extract frees the alkaloids into an organic solvent, and back-extraction into acid gives the salt. This step is what separates a crude extract from an isolated alkaloid.
HPLC quantifies ephedrine and pseudoephedrine so the extract can be adjusted to a declared percentage. Species substitution is a known adulteration route because alkaloid-free Ephedra species look similar once dried.
Traditional use is as a decoction in multi-herb formulas. Supplement-era use was capsules or tablets, a category the US FDA prohibited in 2004 for ephedrine-alkaloid content.
The forms it comes in.
The essence, in one line each.
- Acute ephedra with caffeine altered maximal strength and power output measures relative to placebo in a crossover design.Randomised trial. Williams AD et al., 2008 (Journal of Strength and Conditioning Research). PMID 18550961 ↗
- The authors identified an enzymatic cascade that builds diverse Ephedra-type alkaloids, mapping the biosynthetic route to the plant's characteristic amines.In vitro study. Wu P et al., 2024 (Biodesign Research). PMID 39228751 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Ephedra. The full linked list is below.
The studies, linked.
1 source behind our Ephedra verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Intramuscular Ephedrine on the Incidence of Perioperative Nausea and Vomiting During Elective Cesarean SectionClinicalTrials.gov ↗Phase 2, 53 participants, Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 662 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Ephedra is, not how risky it is. A report is not proof Ephedra caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.